Dec 2022 Articles

Articles
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
Sherratt SCR, Libby P, Budoff MJ, et al.
Journal:
Curr Atheroscler Rep

First published: December 29, 2022 DOI: 10.1007/s11883-022-01075-x
View
- Share
Articles
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial
Lee YJ, Cho JY, You SC, et al.
Journal:
Eur Heart J

First published: December 19, 2022 DOI: 10.1093/eurheartj/ehac709
View
- Share
Articles
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
Marx N, Husain M, Lehrke M, et al.
Journal:
Circulation

First published: December 12, 2022 DOI: 10.1161/CIRCULATIONAHA.122.059595
View
- Share
Articles
Early initiation of PCSK9 inhibition in myocardial infarction could be EPIC for patient care
Bhatt DL
Journal:
EuroIntervention

First published: December 2, 2022 DOI: 10.4244/EIJ-E-22-00047
View
- Share
Articles
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial
Mehta SR, Pare G, Lonn EM, et al.
Journal:
EuroIntervention

First published: December 2, 2022 DOI: 10.4244/EIJ-D-22-00735
View
- Share